Stuart A. Arbuckle, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 612 shares at $263.98 ($162K) on 2022-05-02, disclosed to the SEC on 2022-05-04.
Seasonal sale ($162k) by EVP, COO — this insider has traded VRTX in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $263.98 | 306 | $81K | 50.0% |
| 2 | $263.98 | 306 | $81K | 50.0% |
| Total | $263.98 avg | 612 | $162K | 100% |
| Filing → |
| VRTX | SELL | 2024-02-23 | $3.0M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2024-02-13 | $3.6M | — | Filing → |